Could a blood test help tell whether a lung nodule is cancer? New CIZ1B study offers promising data and an important warning
A peer-reviewed CIZ1B-FibA study reported 94% sensitivity and 97% negative predictive value in one early-stage lung cancer cohort, while identifying pre-analytic variability that must be resolved before broader clinical validation.
